Product Information
NITROGLYCERIN 0.4 MG TABLET SL is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1272 per EA under NDC 59762330403. Its NADAC has been published 511 times since Nov 23, 2016.
FDA first approved this application on May 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.4 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762330403
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
NITROGLYCERINApproval Type
Authorized Generic (NDA)
FDA Application
NDA021134FDA Approved
5/1/2000
TE Code
AB
On Market Since
8/26/2016
Pharmacological Classes
Price Statistics
The NADAC for NITROGLYCERIN 0.4 MG TABLET SL has been published 511 times since Nov 23, 2016, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1272 per EA |
|---|---|
| All-time high | $0.6219 (Jan 11, 2017) |
| All-time low | $0.1272 (Sep 23, 2026) |
| 52-week high | $0.1681 |
| 52-week low | $0.1272 |
| Median price | $0.3083 |
| Average price | $0.3304 |
| Largest weekly change | -23.8% (Oct 23, 2024) |
| Weeks tracked | 511 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nitroglycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrate Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROGLYCERIN 0.4 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for NITROGLYCERIN 0.4 MG TABLET SL, manufactured by Mylan Pharmaceuticals Inc., is $0.1272 per EA (NDC 59762330403), effective Sep 30, 2026.
How has the price of NITROGLYCERIN 0.4 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for NITROGLYCERIN 0.4 MG TABLET SL has declined 77.6%. It has been tracked across 511 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for NITROGLYCERIN 0.4 MG TABLET SL?
Since Nov 23, 2016, the NADAC for NITROGLYCERIN 0.4 MG TABLET SL has ranged from a low of $0.1272 (Sep 23, 2026) to a high of $0.6219 (Jan 11, 2017), with a median of $0.3083 per EA.
Are there cheaper alternatives to NITROGLYCERIN 0.4 MG TABLET SL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROGLYCERIN 0.4 MG TABLET SL, is $0.0787 per EA — about 38% below NITROGLYCERIN 0.4 MG TABLET SL.
Who manufactures NITROGLYCERIN 0.4 MG TABLET SL?
NITROGLYCERIN 0.4 MG TABLET SL (NDC 59762330403) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.